(1/2) This month, executive vice president & chief development officer Bob Dagher of @BrainstormCell presented a poster at the 2024 @MDAorg Clinical and Scientific Conference outlining the proposed design for a Phase 3b trial of NurOwn® in ALS. Learn more: bit.ly/3wYCvk2
1
1
4
157
0
Download Image